Загрузка...
FDA Revisits Rules on Drug and Device Communication: Will the Agency Relax Existing Industry-Opposed Restrictions?
The Food and Drug Administration issued draft guidances in January that tackled health care economic information and product labeling. Do these publications indicate a potential shift in on- and off-label policies for drugs and devices?
Сохранить в:
| Опубликовано в: : | P T |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MediMedia USA, Inc.
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312633/ https://ncbi.nlm.nih.gov/pubmed/28250700 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|